Innovation in bone healing and tissue repair

KUR-113 consists of a natural fibrin-based healing matrix with an immobilized targeted bone growth factor (PTH). KUR-113 is designed to be applied directly into and around an inter-body spinal cage as a gel, where it polymerizes in situ.

This is in contrast to most products on the market which are solids, granules or sponges. Studies show that the combination of the natural healing matrix with the localized bone growth factor induces a response from the adjacent vertebrae, facilitating fusion through the cage.

The program has completed non-clinical testing. 

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kuros.ch

About Kuros

  1. Overview
  2. Executive Committee
  3. Board

Products

  1. Pipeline
  2. Orthobiologics
    Fracture repair
    KUR-111
    KUR-113
    MagnetOs
    Spinal fusion
    KUR-113
    MagnetOs
    Solitary Bone Cysts
    KUR-112
  3. Sealants
    Neuroseal (KUR-023)

Technologies

  1. Overview
  2. Surface Science Technology
  3. Synthetic Cross-Linking Technology
  4. Fibrin-Based
  5. Immune Modulation
  6. Publications

Partnerships

  1. Collaborations
  2. Business development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
KUR-113

KUR-113 consists of a natural fibrin-based healing matrix with an immobilized targeted bone growth factor (PTH). KUR-113 is designed to be applied directly into and around an inter-body spinal cage as a gel, where it polymerizes in situ.

This is in contrast to most products on the market which are solids, granules or sponges. Studies show that the combination of the natural healing matrix with the localized bone growth factor induces a response from the adjacent vertebrae, facilitating fusion through the cage.

The program has completed non-clinical testing.